Histologic Distribution and Characteristics on MR Imaging of Ultrasmall Superparamagnetic Iron Oxide in Ethyl-nitrosourea-induced Endogenous Rat Glioma.

1. Wen PY, Reardon DA. Neuro-oncology in 2015: progress

in glioma diagnosis, classification and treatment. Nat Rev

Neurol 2016; 12:69–70.

2. Johnson DR, Guerin JB, Giannini C, Morris JM, Eckel LJ,

Kaufmann TJ. 2016 updates to the WHO brain tumor

classification system: what the radiologist needs to know.

Radiographics 2017; 37:2164–2180.

3. Zhang J, Liu H, Tong H, et al. Clinical applications of

contrast-enhanced perfusion mri techniques in gliomas:

Vol. 20, No. 3

recent advances and current challenges. Contrast Media

Mol Imaging 2017; 2017:7064120.

4. Enochs WS, Harsh G, Hochberg F, Weissleder R. Improved

delineation of human brain tumors on MR images using

a long-circulating, superparamagnetic iron oxide agent.

J Magn Reson Imaging 1999; 9:228–232.

5. Taschner CA, Wetzel SG, Tolnay M, Froehlich J, Merlo A,

Radue EW. Characteristics of ultrasmall superparamagnetic

iron oxides in patients with brain tumors. AJR Am J

Roentgenol 2005; 185:1477–1486.

6. Muldoon LL, Sàndor M, Pinkston KE, Neuwelt EA. Imaging,

distribution, and toxicity of superparamagnetic iron oxide

magnetic resonance nanoparticles in the rat brain and

intracerebral tumor. Neurosurgery 2005; 57:785–796.

7. Neuwelt EA, Várallyay CG, Manninger S, et al. The

potential of ferumoxytol nanoparticle magnetic resonance

imaging, perfusion, and angiography in central nervous

system malignancy: a pilot study. Neurosurgery 2007;

60:601–611; discussion 611–612.

8. Beaumont M, Lemasson B, Farion R, Segebarth C, Rémy C,

Barbier EL. Characterization of tumor angiogenesis in rat

brain using iron-based vessel size index MRI in combination

with gadolinium-based dynamic contrast-enhanced MRI. J

Cereb Blood Flow Metab 2009; 29:1714–1726.

9. Weinstein JS, Varallyay CG, Dosa E, et al.

Superparamagnetic iron oxide nanoparticles: diagnostic

magnetic resonance imaging and potential therapeutic

applications in neurooncology and central nervous system

inflammatory pathologies, a review. J Cereb Blood Flow

Metab 2010; 30:15–35.

10. Gahramanov S, Muldoon LL, Li X, Neuwelt EA. Improved

perfusion MR imaging assessment of intracerebral tumor

blood volume and antiangiogenic therapy efficacy in a rat

model with ferumoxytol. Radiology 2011; 261:796–804.

11. Daldrup-Link HE. Ten things you might not know about

iron oxide nanoparticles. Radiology 2017; 284:616–629.

12. Li W, Graeber MB. The molecular profile of microglia under

the influence of glioma. Neuro-oncology 2012; 14:958–978.

13. Doblas S, He T, Saunders D, et al. Glioma morphology

and tumor-induced vascular alterations revealed in seven

rodent glioma models by in vivo magnetic resonance

imaging and angiography. J Magn Reson Imaging 2010;

32:267–275.

14. Dósa E, Guillaume DJ, Haluska M, et al. Magnetic

resonance imaging of intracranial tumors: intra-patient

comparison of gadoteridol and ferumoxytol. Neurooncology 2011; 13:251–260.

15. Gambarota G, Leenders W, Maass C, et al. Characterisation

of tumour vasculature in mouse brain by USPIO contrastenhanced MRI. Br J Cancer 2008; 98:1784–1789.

16. Troprès I, Lamalle L, Péoc’h M, et al. In vivo assessment of

tumoral angiogenesis. Magn Reson Med 2004; 51:533–541.

271

...